MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 56 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 3,037,971 | $4,010,122 | 1.97% |
| Rubric Capital Management LP | 11,616,120 | $15,333,278 | 0.66% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $9,721,058 | 0.52% |
| 683 Capital Management, LLC | 5,400,000 | $7,128,000 | 0.51% |
| MANGROVE PARTNERS IM, LLC | 5,531,547 | $7,301,642 | 0.51% |
| DAFNA Capital Management LLC | 1,009,013 | $1,331,897 | 0.36% |
| Monaco Asset Management SAM | 705,729 | $931,562 | 0.26% |
| Rock Springs Capital Management LP | 7,042,391 | $9,295,956 | 0.22% |
| Privium Fund Management (UK) Ltd | 177,200 | $225,044 | 0.18% |
| Clearline Capital LP | 1,945,040 | $2,567,453 | 0.15% |
| Boxer Capital, LLC | 2,250,000 | $2,970 | 0.14% |
| Tekla Capital Management LLC | 1,551,082 | $2,047,428 | 0.08% |
| Forefront Analytics, LLC | 82,749 | $109,229 | 0.06% |
| Ikarian Capital, LLC | 891,676 | $300,235 | 0.05% |
| Privium Fund Management B.V. | 177,200 | $225,044 | 0.05% |
| Baker Brothers Advisors | 3,554,979 | $4,692,572 | 0.03% |
| J. Goldman & Co LP | 350,985 | $463,300 | 0.02% |
| Tidal Investments LLC | 331,914 | $438 | 0.01% |
| Alkeon Capital Management | 3,738,100 | $4,934,292 | 0.01% |
| Clear Harbor Asset Management, LLC | 56,754 | $74,915 | 0.01% |
External links
This page lists MEREO BIOPHARMA GROUP PLC's shareholders in Q2 2023. To view MEREO BIOPHARMA GROUP PLC's shareholder history, click here.